Evidence map›Paper›PMID 23740787›Full record

ArticleAngewandte Chemie (International ed. in English)2013

Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo.

Tae Hyung Kim, Magdalena Swierczewska, Yumin Oh, AeRyon Kim, Dong Gyu Jo, Jae Hyung Park, Youngro Byun, Scheherazade Sadegh-Nasseri, Martin G Pomper, Kang Choon Lee and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Site-Specific PEGylation of Therapeutic Proteins.International journal of molecular sciences · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tae Hyung KimRussell H. Morgan Department of Radiology and Radiological Science, Center for Cancer Nanotechnology Excellence, Johns Hopkins University, 400 North Broadway, Baltimore, MD 21231, USA.
Magdalena Swierczewska
Yumin Oh
AeRyon Kim
Dong Gyu Jo
Jae Hyung Park
Youngro Byun
Scheherazade Sadegh-Nasseri
Martin G Pomper
Kang Choon Lee
Seulki Lee

Funding

ValidationU54CA151838 · NCI · JOHNS HOPKINS UNIVERSITY · PI HANES, JUSTIN S. · 2010 to 2014
$11.9M
Role of DM in Generation of Immunodominant Epitope(s)R01AI063764 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2006 to 2015
$3.6M
T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer ResearchT32CA153952 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz · 2015 to 2026
$3.5M
T-32 NIH Postdoctoral Training Program in Nanotechnology for Cancer Medicine NTCMT32CA130840 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2008 to 2012
$1.2M
Development of preclinical HTS for discovery of drugs modulating apoptosisR00EB013450 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI LEE, SEULKI · 2013 to 2015
$718k
NCI NIH HHS T32 CA130840NCI NIH HHS T32 CA153952NCI NIH HHS U54 CA151838NCI NIH HHS U54CA151838NIAID NIH HHS 2R01AI063764-06NIAID NIH HHS R01 AI063764NIBIB NIH HHS R00 EB013450NIBIB NIH HHS R00EB013450NIBIB NIH HHS T32EB013450
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Evaluation, PreclinicalHumansPolyethylene GlycolsProtein Modification, TranslationalProteinsPolyethylene GlycolsProteins

Identifiers

PMID23740787
PMCPMC3902477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.